Cargando…

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer

A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its “in silico” predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Crippa, Elisabetta, Lusa, Lara, De Cecco, Loris, Marchesi, Edoardo, Calin, George Adrian, Radice, Paolo, Manoukian, Siranoush, Peissel, Bernard, Daidone, Maria Grazia, Gariboldi, Manuela, Pierotti, Marco Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903605/
https://www.ncbi.nlm.nih.gov/pubmed/24475217
http://dx.doi.org/10.1371/journal.pone.0087039
_version_ 1782301120406749184
author Crippa, Elisabetta
Lusa, Lara
De Cecco, Loris
Marchesi, Edoardo
Calin, George Adrian
Radice, Paolo
Manoukian, Siranoush
Peissel, Bernard
Daidone, Maria Grazia
Gariboldi, Manuela
Pierotti, Marco Alessandro
author_facet Crippa, Elisabetta
Lusa, Lara
De Cecco, Loris
Marchesi, Edoardo
Calin, George Adrian
Radice, Paolo
Manoukian, Siranoush
Peissel, Bernard
Daidone, Maria Grazia
Gariboldi, Manuela
Pierotti, Marco Alessandro
author_sort Crippa, Elisabetta
collection PubMed
description A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its “in silico” predicted putative target gene ID4, a transcription factor of the helix-loop-helix protein family whose expression is inversely correlated with that of ER. ID4 is expressed in breast cancer and can negatively regulate BRCA1 expression. Our results showed an inverse correlation between ID4 and miR-342 as well as between ID4 and BRCA1 expression. We functionally validated the interaction between ID4 and miR-342 in a reporter Luciferase system. Based on these findings, we hypothesized that regulation of ID4 mediated by miR-342 could be involved in the pathogenesis of breast cancer by downregulating BRCA1 expression. We functionally demonstrated the interactions between miR-342, ID4 and BRCA1 in a model provided by ER-negative MDA-MB-231 breast cancer cell line that presented high levels of ID4. Overexpression of miR-342 in these cells reduced ID4 and increased BRCA1 expression, supporting a possible role of this mechanism in breast cancer. In the ER-positive MCF7 and in the BRCA1-mutant HCC1937 cell lines miR-342 over-expression only reduced ID4. In the cohort of patients we studied, a correlation between miR-342 and BRCA1 expression was found in the ER-negative cases. As ER-negative cases were mainly BRCA1-mutant, we speculate that the mechanism we demonstrated could be involved in the decreased expression of BRCA1 frequently observed in non BRCA1-mutant breast cancers and could be implicated as a causal factor in part of the familial cases grouped in the heterogeneous class of non BRCA1 or BRCA2-mutant cases (BRCAx). To validate this hypothesis, the study should be extended to a larger cohort of ER-negative cases, including those belonging to the BRCAx class.
format Online
Article
Text
id pubmed-3903605
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39036052014-01-28 miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer Crippa, Elisabetta Lusa, Lara De Cecco, Loris Marchesi, Edoardo Calin, George Adrian Radice, Paolo Manoukian, Siranoush Peissel, Bernard Daidone, Maria Grazia Gariboldi, Manuela Pierotti, Marco Alessandro PLoS One Research Article A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its “in silico” predicted putative target gene ID4, a transcription factor of the helix-loop-helix protein family whose expression is inversely correlated with that of ER. ID4 is expressed in breast cancer and can negatively regulate BRCA1 expression. Our results showed an inverse correlation between ID4 and miR-342 as well as between ID4 and BRCA1 expression. We functionally validated the interaction between ID4 and miR-342 in a reporter Luciferase system. Based on these findings, we hypothesized that regulation of ID4 mediated by miR-342 could be involved in the pathogenesis of breast cancer by downregulating BRCA1 expression. We functionally demonstrated the interactions between miR-342, ID4 and BRCA1 in a model provided by ER-negative MDA-MB-231 breast cancer cell line that presented high levels of ID4. Overexpression of miR-342 in these cells reduced ID4 and increased BRCA1 expression, supporting a possible role of this mechanism in breast cancer. In the ER-positive MCF7 and in the BRCA1-mutant HCC1937 cell lines miR-342 over-expression only reduced ID4. In the cohort of patients we studied, a correlation between miR-342 and BRCA1 expression was found in the ER-negative cases. As ER-negative cases were mainly BRCA1-mutant, we speculate that the mechanism we demonstrated could be involved in the decreased expression of BRCA1 frequently observed in non BRCA1-mutant breast cancers and could be implicated as a causal factor in part of the familial cases grouped in the heterogeneous class of non BRCA1 or BRCA2-mutant cases (BRCAx). To validate this hypothesis, the study should be extended to a larger cohort of ER-negative cases, including those belonging to the BRCAx class. Public Library of Science 2014-01-27 /pmc/articles/PMC3903605/ /pubmed/24475217 http://dx.doi.org/10.1371/journal.pone.0087039 Text en © 2014 Crippa et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Crippa, Elisabetta
Lusa, Lara
De Cecco, Loris
Marchesi, Edoardo
Calin, George Adrian
Radice, Paolo
Manoukian, Siranoush
Peissel, Bernard
Daidone, Maria Grazia
Gariboldi, Manuela
Pierotti, Marco Alessandro
miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
title miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
title_full miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
title_fullStr miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
title_full_unstemmed miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
title_short miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
title_sort mir-342 regulates brca1 expression through modulation of id4 in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903605/
https://www.ncbi.nlm.nih.gov/pubmed/24475217
http://dx.doi.org/10.1371/journal.pone.0087039
work_keys_str_mv AT crippaelisabetta mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT lusalara mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT dececcoloris mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT marchesiedoardo mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT calingeorgeadrian mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT radicepaolo mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT manoukiansiranoush mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT peisselbernard mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT daidonemariagrazia mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT gariboldimanuela mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer
AT pierottimarcoalessandro mir342regulatesbrca1expressionthroughmodulationofid4inbreastcancer